Replimune Group, Inc. — Director's Dealing 2019

Apr 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2019-04-01

Reporting Person: Kaufman Howard (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-01	Employee Stock Option (right to buy)	$15.50	A	80500	Acquired	2029-04-01	Common Stock (80500)	Direct

Footnotes

F1: 25% of the shares underlying this stock option vest on April 1, 2020, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.